Regeneron Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (27 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 155,215 | 0.1% | 201,090 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 114,205 | 0.1% | 203,114 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 165,226 | 0.1% | 314,716 | 6/30/2025 |
| 2025 Q1 | 5/13/2025 | 300,276 | 0.2% | 473,450 | 3/31/2025 |
| 2024 Q4 | 4/23/2025 | 258,929 | 0.2% | 363,496 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 390,681 | 0.3% | 371,638 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 396,164 | 0.3% | 376,929 | 6/30/2024 |
| 2024 Q1 | 4/30/2024 | 391,789 | 0.3% | 407,058 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 362,301 | 0.3% | 412,507 | 12/31/2023 |
| 2023 Q3 | 11/2/2023 | 345,844 | 0.3% | 420,244 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 401,494 | 0.3% | 558,764 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 471,484 | 0.4% | 573,812 | 3/31/2023 |
| 2022 Q4 | 2/8/2023 | 442,328 | 0.4% | 613,076 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 511,966 | 0.5% | 743,197 | 9/30/2022 |
| 2022 Q2 | 8/10/2022 | 452,736 | 0.4% | 765,883 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 541,932 | 0.4% | 775,940 | 3/31/2022 |
| 2021 Q4 | 2/10/2022 | 494,740 | 0.3% | 783,412 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 485,765 | 0.4% | 802,679 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 444,458 | 0.3% | 795,750 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 374,839 | 0.3% | 792,236 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 400,316 | 0.3% | 828,623 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 465,066 | 0.4% | 830,801 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 522,617 | 0.5% | 837,998 | 6/30/2020 |
| 2020 Q1 | 5/12/2020 | 89,841 | 0.1% | 183,991 | 3/31/2020 |
| 2019 Q4 | 1/27/2020 | 73,003 | 0.1% | 194,425 | 12/31/2019 |
| 2014 Q1 | 4/18/2014 | 63,495 | 0.1% | 221,670 | 3/31/2014 |
| 2013 Q4 | 2/13/2014 | 65,300 | 0.1% | 234,354 | 12/31/2013 |